Cartesian Therapeutics' lead asset, Descartes-08, demonstrated a 7.1-point MG-ADL reduction at 12 months in Phase 2b. Find ...
Anthropic on April 24 published the results of “Project Deal,” a one-week internal experiment in which Claude agents bought ...
Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Robert Kelly is managing director of XTS ...
US Supreme Court hears Bayer's fight against Roundup lawsuits The U.S. Supreme Court is set on Monday to consider Bayer AG's effort to shut down thousands of lawsuits accusing the company of failing ...
Find out the direct holders, institutional holders and mutual fund holders for Cartesian Therapeutics, Inc. (RNAC).
AMD Ryzen 9 9950X3D2 Dual Edition Review:... Intel Core Series 3 Launched: Wildcat Lake... A Tiny NAS With Big Storage: Beelink Me Pro &... iPhone 17e Review: Apple Just Perfected Its... Qualcomm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results